Probiotics improve CAP/ steatosis in both obese and non-obese NAFLD patients and improvement was higher in non-obese, irrespective of BMI change.
Keyphrases
- adipose tissue
- weight loss
- metabolic syndrome
- insulin resistance
- end stage renal disease
- type diabetes
- high fat diet
- obese patients
- newly diagnosed
- ejection fraction
- chronic kidney disease
- body mass index
- prognostic factors
- peritoneal dialysis
- bariatric surgery
- physical activity
- patient reported outcomes
- skeletal muscle
- liver fibrosis